Chau Sek Hung, Jansen Aaltje P D, van de Ven Peter M, Hoogland Petra, Elders Petra J M, Hugtenburg Jacqueline G
Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
The EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Int J Clin Pharm. 2016 Feb;38(1):46-53. doi: 10.1007/s11096-015-0199-8. Epub 2015 Nov 23.
Knowledge of drug-related problems (DRPs) identified in the medication of home-dwelling elderly patients with polypharmacy has been based predominantly on medication reviews conducted in research settings rather than in daily practice.
To evaluate the prevalence of DRPs identified by means of a clinical medication review (CMR) and the implementation rate of proposed interventions in a large group of older patients with polypharmacy in the daily practice of community pharmacies.
318 Dutch community pharmacies.
A cross-sectional study based on CMR-data of 3807 older patients (≥65 years) with polypharmacy (≥5 drugs) completed between January and August 2012. Data were extracted from community pharmacists' databases and entailed: year of birth, gender, dispensing data, number and nature of identified DRPs, consultations performed, proposed and implemented interventions. Main outcome measure Prevalence of DRPs, drug classes involved in overtreatment and undertreatment, and proposed and implemented interventions.
A median of two DRPs (interquartile range 1-4; mean 3.0) was identified per patient. The DRP-categories overtreatment (25.5 %) and undertreatment (15.9 %) were found most frequently. 46.2 % of the proposed interventions to solve DRPs were implemented as proposed, in 22.4 % of cases, the intervention differed from the proposal. In 31.3 % of cases no intervention was implemented.
By conducting a CMR community pharmacists identified a median of two DRPs in older patients with polypharmacy. Overtreatment and undertreatment accounted for 41.4 % of the DRPs identified. In dealing with DRPs, pharmacists proposed a variety of interventions of which the majority (69.9 %) was either implemented or led to alternative interventions. A set of explicit criteria should be applied during a CMR to solve and prevent DRPs.
在居家多药合用的老年患者用药过程中发现的药物相关问题(DRP)的相关知识,主要基于在研究环境而非日常实践中进行的用药评估。
在社区药房的日常实践中,评估通过临床用药评估(CMR)识别出的DRP的患病率以及在一大群多药合用的老年患者中所提出干预措施的实施率。
318家荷兰社区药房。
一项横断面研究,基于2012年1月至8月间完成的3807名多药合用(≥5种药物)的老年患者(≥65岁)的CMR数据。数据从社区药剂师数据库中提取,包括:出生年份、性别、配药数据、识别出的DRP的数量和性质、进行的咨询、提出和实施的干预措施。主要结局指标:DRP的患病率、过度治疗和治疗不足中涉及的药物类别,以及提出和实施的干预措施。
每位患者识别出的DRP中位数为2个(四分位间距1 - 4;均值3.0)。最常发现的DRP类别是过度治疗(25.5%)和治疗不足(15.9%)。为解决DRP而提出的干预措施中,46.2%按提议实施,22.4%的情况中,干预措施与提议不同。31.3%的情况未实施干预措施。
通过进行CMR,社区药剂师在多药合用的老年患者中识别出的DRP中位数为2个。过度治疗和治疗不足占所识别出的DRP的41.4%。在处理DRP时,药剂师提出了多种干预措施,其中大多数(69.9%)要么得以实施,要么导致了替代干预措施。在CMR期间应应用一套明确的标准来解决和预防DRP。